Johnson & Johnson
Change company Symbol lookup
Select an option...
JNJ Johnson & Johnson
VIPS Vipshop Holdings Ltd
CAT Caterpillar Inc
AAPL Apple Inc
ESLT Elbit Systems Ltd
AZO Autozone Inc
DITTF Daito Trust Construction Co Ltd
MYO Myomo Inc
CRVS Corvus Pharmaceuticals Inc

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.


Last Trade
-0.03 (-0.02%)
B/A Size

Market Hours

Closing Price
Day's Change
0.33 (0.23%)
B/A Size
Day's High
Day's Low
(Above Average)

10-day average volume:

UPDATE: HPE loses more than $800 million as sales slump, CEO blames coronavirus 'economic lockdowns'

5:55 pm ET May 21, 2020 (MarketWatch)

By Jon Swartz

Stock falls 5% in after-hours trading, Neri introduces three-year plan to cut $1 billion in costs

Hewlett Packard Enterprise Co. shares slipped about 5% in after-hours trading Thursday after the computing giant reported fiscal second-quarter results that fell short of Wall Street estimates.

HPE (HPE) reported a loss of $821 million, or 64 cents a share, on revenue of $6.01 billion, down 16% from $7.15 billion a year ago. After adjustments for an $865 million impairment charge and other effects, the company reported earnings of 22 cents a share, down from adjusted earnings of 42 cents a share a year ago.

The company, which pointed to supply chain constraints as part of the problem, offered no financial guidance for the current quarter or fiscal year.

Analysts surveyed by FactSet had expected adjusted earnings of 30 cents a share on sales of $6.33 billion.

"The global economic lockdowns since February significantly impacted our fiscal Q2 financial performance," HPE Chief Executive Antonio Neri said in a statement announcing the results. "We exited Q2 with $1.5 billion in orders across the portfolio, representing two times the average historical backlog."

"We are taking decisive steps to navigate the near-term uncertainty, while ensuring we align resources to priority growth areas so that we are well positioned to accelerate our edge-to-cloud strategy and address the needs of our customers in a post-COVID-19 world," Neri said.

Chief Financial Officer Tarek Robbiati deemed the economic climate "very difficult" and told MarketWatch the company is exploring cost reductions that could include layoffs, furloughs, and hiring restrictions to "right-size" operations.

Among the other measures HPE is taking are 25% salary cuts for Neri and executive vice presidents through 2020, as well as "changes to its workforce" meant to shave $1 billion in future costs.

A.B. Bernstein analyst Toni Sacconaghi, echoing the concerns of other analysts on the conference call, expressed wariness over what he called another "significant multi-year effort" by HPE to slash costs. Neri characterized this quarter as a supply issue because of coronavirus vs. a dip in IT demand last year.

The outbreak of COVID-19 went far beyond an economic thrashing: Neri estimated that half of HPE's employees will permanently work from home, and those who do return to the office will find radically restructured facilities.

HPE shares are down 34.7% this year while the S&P 500 index is down 8.7%.

-Jon Swartz; 415-439-6400;

(END) Dow Jones Newswires

May 21, 2020 17:55 ET (21:55 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.